An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Standard BioTools Inc. announces a conference call and webcast for the first quarter 2024 financial results on May 8, 2024. The Company will report the financial results after the market closes. The management will discuss the results and operational progress during the conference call and webcast. Interested individuals can listen to the call by dialing specific numbers or accessing the live audio webcast on the Company's website. The webcast will be archived for future reference.
Standard BioTools Inc. annuncia una conferenza telefonica e un webcast per la presentazione dei risultati finanziari del primo trimestre del 2024 il giorno 8 maggio 2024. La società comunicherà i risultati finanziari dopo la chiusura del mercato. I dirigenti discuteranno i risultati e i progressi operativi durante la conferenza telefonica e il webcast. Le persone interessate possono ascoltare la conferenza telefonando a numeri specifici o accedendo al webcast audio dal vivo sul sito web della società. Il webcast sarà archiviato per future consultazioni.
Standard BioTools Inc. anuncia una llamada de conferencia y un webcast para los resultados financieros del primer trimestre de 2024 el 8 de mayo de 2024. La compañía reportará los resultados financieros después del cierre del mercado. La gerencia discutirá los resultados y el progreso operativo durante la llamada de conferencia y el webcast. Los interesados pueden escuchar la llamada marcando números específicos o accediendo al webcast de audio en vivo en el sitio web de la compañía. El webcast se archivará para futura referencia.
스탠다드 바이오툴즈 인크가 2024년 5월 8일에 첫 분기 재무 결과를 발표하기 위한 컨퍼런스 콜과 웹캐스트를 발표하였습니다. 회사는 시장 종료 후에 재무 결과를 보고할 것입니다. 경영진은 컨퍼런스 콜과 웹캐스트 동안 결과와 운영 진행 상황을 논의할 것입니다. 관심 있는 개인은 특정 번호를 다이얼하거나 회사 웹사이트에서 생방송 오디오 웹캐스트에 접속하여 들을 수 있습니다. 웹캐스트는 나중에 참조할 수 있도록 보관될 것입니다.
Standard BioTools Inc. annonce une conférence téléphonique et un webcast pour les résultats financiers du premier trimestre 2024 le 8 mai 2024. L'entreprise communiquera les résultats financiers après la fermeture des marchés. La direction discutera des résultats et des progrès opérationnels pendant la conférence téléphonique et le webcast. Les personnes intéressées peuvent écouter l'appel en composant des numéros spécifiques ou en accédant au webcast audio en direct sur le site web de l'entreprise. Le webcast sera archivé pour référence future.
Standard BioTools Inc. kündigt einen Telefonkonferenz und ein Webcast an, um die Finanzergebnisse für das erste Quartal 2024 am 8. Mai 2024 zu präsentieren. Das Unternehmen wird die Finanzergebnisse nach Börsenschluss melden. Das Management wird die Ergebnisse und den betrieblichen Fortschritt während der Telefonkonferenz und des Webcasts besprechen. Interessierte Personen können den Anruf anhören, indem sie bestimmte Nummern wählen oder auf das live Audio-Webcast auf der Website des Unternehmens zugreifen. Der Webcast wird für zukünftige Referenzen archiviert.
Positive
None.
Negative
None.
SOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced that it will report first quarter 2024 financial results on Wednesday, May 8, 2024, after the close of the market.
The Company’s management will host a conference call and webcast at 1:30 p.m. PT, 4:30 p.m. ET, on May 8, 2024, to discuss first quarter 2024 financial results and operational progress. A press release including the financial results will be publicly distributed before the call.
Individuals interested in listening to the conference call may do so by dialing:
US domestic callers: (888) 346-3970 Outside US callers: (412) 902-4297
Live audio of the webcast will be available online on the Investor Relations page of the Company’s website at Events & Presentations. The webcast will be archived and available on Standard BioTools™ Investor Relations page at investors.standardbio.com.
About Standard BioTools Inc.
Standard BioTools Inc. (Nasdaq:LAB), the parent company of SomaLogic Inc. and previously known as Fluidigm Corporation, is driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health. Standard BioTools has an established portfolio of essential, standardized next-generation technologies that help biomedical researchers develop medicines faster and better. As a leading solutions provider, the company provides reliable and repeatable insights in health and disease using its proprietary mass cytometry and microfluidics technologies, which help transform scientific discoveries into better patient outcomes. Standard BioTools works with leading academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology and immunotherapy. Learn more at standardbio.com or connect with us on X, Facebook®, LinkedIn, and YouTube™.
For Research Use Only. Not for use in diagnostic procedures.
When will Standard BioTools announce the first quarter 2024 financial results?
Standard BioTools will announce the first quarter 2024 financial results on May 8, 2024, after the market closes.
What time will the conference call and webcast regarding the financial results take place?
The conference call and webcast will be held at 1:30 p.m. PT, 4:30 p.m. ET, on May 8, 2024.
How can individuals listen to the conference call?
Interested individuals can listen to the conference call by dialing (888) 346-3970 for US domestic callers or (412) 902-4297 for outside US callers.
Where can the live audio webcast of the conference call be accessed?
The live audio webcast of the conference call can be accessed on the Investor Relations page of Standard BioTools' website under Events & Presentations.
Will the webcast be available for future reference?
Yes, the webcast will be archived and available on Standard BioTools' Investor Relations page at investors.standardbio.com.
fluidigm (nasdaq:fldm) develops, manufactures and markets microfluidic systems for growth markets in the life sciences and in applied markets. fluidigm’s systems consist of instruments, software, integrated fluidic circuits (ifcs), high-performance assays for gene expression and genotyping, and primers for sample preparation for next-generation sequencing. fluidigm technology enables customers to perform thousands of sophisticated biochemical measurements in parallel on samples smaller than the content of a single cell, with nanoliter volumes of reagents, in half the area of a credit card. the company’s integrated customer solutions are designed to significantly simplify experimental workflows, increase throughput and reduce costs while delivering excellent data quality. based in south san francisco, fluidigm offers an exciting and collegial working environment with excellent compensation and benefits, including equity.
